Countering deleterious phase transitions in ALS/FTD

James  Shorter, PhD, is a professor of biochemistry and biophysics at the University of Pennsylvania. He received his MA in Biology from the University of Oxford and a PhD in Cell Biology from University College London. His postdoctoral training was at Yale University and the Whitehead Institute for Biomedical Research at MIT. His lab focuses on mechanisms to counter deleterious phase transitions in neurodegenerative disease.
Talk Description: Countering deleterious phase transitions in ALS/FTD. In this talk, Dr. Shorter will provide his thoughts on how to counter deleterious phase transitions in ALS/FTD.